Low intrinsic running capacity is associated with reduced skeletal muscle substrate oxidation and lower mitochondrial content in white skeletal muscle.

Chronic metabolic diseases develop from the complex interaction of environmental and genetic factors, although the extent to which each contributes to these disorders is unknown. Here, we test the hypothesis that artificial selection for low intrinsic aerobic running capacity is associated with reduced skeletal muscle metabolism and impaired metabolic health. Rat models for low- (LCR) and high- (HCR) intrinsic running capacity were derived from genetically heterogeneous N:NIH stock for 20 generations. Artificial selection produced a 530% difference in running capacity between LCR/HCR, which was associated with significant functional differences in glucose and lipid handling by skeletal muscle, as assessed by hindlimb perfusion. LCR had reduced rates of skeletal muscle glucose uptake (∼30%; P = 0.04), glucose oxidation (∼50%; P = 0.04), and lipid oxidation (∼40%; P = 0.02). Artificial selection for low aerobic capacity was also linked with reduced molecular signaling, decreased muscle glycogen, and triglyceride storage, and a lower mitochondrial content in skeletal muscle, with the most profound changes to these parameters evident in white rather than red muscle. We show that a low intrinsic aerobic running capacity confers reduced insulin sensitivity in skeletal muscle and is associated with impaired markers of metabolic health compared with high intrinsic running capacity. Furthermore, selection for high running capacity, in the absence of exercise training, endows increased skeletal muscle insulin sensitivity and oxidative capacity in specifically white muscle rather than red muscle. These data provide evidence that differences in white muscle may have a role in the divergent aerobic capacity observed in this generation of LCR/HCR.

[1]  Jack Coulehan,et al.  Family History , 2014, Annals of Internal Medicine.

[2]  S. Pande On rate-controlling factors of long chain fatty acid oxidation. , 1971, The Journal of biological chemistry.

[3]  R. Hickson,et al.  Skeletal muscle enzyme alterations after sprint and endurance training. , 1976, Journal of applied physiology.

[4]  R. DeFronzo,et al.  Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. , 1985, The Journal of clinical investigation.

[5]  D. James,et al.  Intrinsic differences of insulin receptor kinase activity in red and white muscle. , 1986, The Journal of biological chemistry.

[6]  C. Maltin,et al.  Fiber-type composition of nine rat muscles. I. Changes during the first year of life. , 1989, The American journal of physiology.

[7]  P. Thompson,et al.  Utilization of glycogen but not plasma glucose is reduced in individuals with NIDDM during mild-intensity exercise. , 1996, Journal of applied physiology.

[8]  J. Simoneau,et al.  Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. , 1997, Journal of applied physiology.

[9]  A. Astrup,et al.  Fat metabolism in formerly obese women. , 1998, American journal of physiology. Endocrinology and metabolism.

[10]  J. Zierath,et al.  Muscle fiber type-specific defects in insulin signal transduction to glucose transport in diabetic GK rats. , 1999, Diabetes.

[11]  J. Zierath,et al.  Muscle fiber type specificity in insulin signal transduction. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

[12]  P. Hespel,et al.  Regulation of glycogen breakdown by glycogen level in contracting rat muscle. , 1999, Acta physiologica Scandinavica.

[13]  S. Gordon,et al.  Waging war on modern chronic diseases: primary prevention through exercise biology , 2000, Journal of applied physiology.

[14]  L. Mandarino,et al.  Fuel selection in human skeletal muscle in insulin resistance: a reexamination. , 2000, Diabetes.

[15]  K. Esser,et al.  Intracellular signaling specificity in skeletal muscle in response to different modes of exercise. , 2001, Journal of applied physiology.

[16]  Simon C Watkins,et al.  Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. , 2001, The Journal of clinical endocrinology and metabolism.

[17]  L. Koch,et al.  Artificial selection for intrinsic aerobic endurance running capacity in rats. , 2001, Physiological genomics.

[18]  J. DiMaio,et al.  Activation of MEF2 by muscle activity is mediated through a calcineurin‐dependent pathway , 2001, The EMBO journal.

[19]  B. Goodpaster,et al.  Muscle triglyceride and insulin resistance. , 2002, Annual review of nutrition.

[20]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[21]  D. G. Newman,et al.  Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status. , 2003, The Journal of clinical endocrinology and metabolism.

[22]  A. Butte,et al.  Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Raymond M. Kraus,et al.  Impaired plasma fatty acid oxidation in extremely obese women. , 2004, American journal of physiology. Endocrinology and metabolism.

[24]  R. Evans,et al.  Regulation of Muscle Fiber Type and Running Endurance by PPARδ , 2004, PLoS biology.

[25]  J. Hawley,et al.  Open access, freely available online Primer Skeletal Muscle Fiber Type: Influence on Contractile and Metabolic Properties , 2022 .

[26]  A. Crain,et al.  Chronic leptin treatment enhances insulin-stimulated glucose disposal in skeletal muscle of high-fat fed rodents. , 2004, Life sciences.

[27]  P. Schrauwen,et al.  Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes. , 2004, Diabetes.

[28]  David E James,et al.  Characterization of the Role of the Rab GTPase-activating Protein AS160 in Insulin-regulated GLUT4 Trafficking* , 2005, Journal of Biological Chemistry.

[29]  Christoph Handschin,et al.  Metabolic control through the PGC-1 family of transcription coactivators. , 2005, Cell metabolism.

[30]  Ø. Ellingsen,et al.  Cardiovascular Risk Factors Emerge After Artificial Selection for Low Aerobic Capacity , 2005, Science.

[31]  D. Kelley Skeletal muscle fat oxidation: timing and flexibility are everything. , 2005, The Journal of clinical investigation.

[32]  K. Petersen,et al.  Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. , 2005, The Journal of clinical investigation.

[33]  D. Hood,et al.  Coordination of metabolic plasticity in skeletal muscle , 2006, Journal of Experimental Biology.

[34]  K. Petersen,et al.  Molecular Mechanisms of Insulin Resistance in Humans and Their Potential Links With Mitochondrial Dysfunction , 2006, Diabetes.

[35]  W. Backes,et al.  Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects , 2006, Diabetologia.

[36]  K. Petersen,et al.  Etiology of insulin resistance. , 2006, The American journal of medicine.

[37]  G. Duncan Exercise, fitness, and cardiovascular disease risk in type 2 diabetes and the metabolic syndrome , 2006, Current diabetes reports.

[38]  G. Heigenhauser,et al.  Skeletal muscle mitochondrial FAT/CD36 content and palmitate oxidation are not decreased in obese women. , 2007, American journal of physiology. Endocrinology and metabolism.

[39]  J. Zierath,et al.  Insulin signaling and glucose transport in insulin resistant human skeletal muscle , 2007, Cell Biochemistry and Biophysics.

[40]  X. Papademetris,et al.  The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome , 2007, Proceedings of the National Academy of Sciences.

[41]  K. Petersen,et al.  Impaired Mitochondrial Substrate Oxidation in Muscle of Insulin-Resistant Offspring of Type 2 Diabetic Patients , 2007, Diabetes.

[42]  N. Turner,et al.  Overexpression of carnitine palmitoyltransferase I in skeletal muscle in vivo increases fatty acid oxidation and reduces triacylglycerol esterification. , 2007, American journal of physiology. Endocrinology and metabolism.

[43]  G. Bray,et al.  Family History of Diabetes Links Impaired Substrate Switching and Reduced Mitochondrial Content in Skeletal Muscle , 2007, Diabetes.

[44]  L. Koch,et al.  Artificial selection for high-capacity endurance running is protective against high-fat diet-induced insulin resistance. , 2007, American journal of physiology. Endocrinology and metabolism.

[45]  M. Febbraio,et al.  Tissue-Specific Effects of Rosiglitazone and Exercise in the Treatment of Lipid-Induced Insulin Resistance , 2007, Diabetes.

[46]  E. Ravussin,et al.  Metabolic flexibility and insulin resistance. , 2008, American journal of physiology. Endocrinology and metabolism.

[47]  L. Groop,et al.  New Insights into Impaired Muscle Glycogen Synthesis , 2008, PLoS medicine.

[48]  J. Hawley,et al.  Skeletal muscle adaptation and performance responses to once a day versus twice every second day endurance training regimens. , 2008, Journal of applied physiology.

[49]  D. Hood,et al.  Kinase-specific responsiveness to incremental contractile activity in skeletal muscle with low and high mitochondrial content. , 2008, American journal of physiology. Endocrinology and metabolism.

[50]  F. Toledo,et al.  Mitochondrial Capacity in Skeletal Muscle Is Not Stimulated by Weight Loss Despite Increases in Insulin Action and Decreases in Intramyocellular Lipid Content , 2008, Diabetes.

[51]  J. Hawley,et al.  Exercise training‐induced improvements in insulin action , 2007, Acta physiologica.

[52]  E. Olson,et al.  Calsarcin-2 deficiency increases exercise capacity in mice through calcineurin/NFAT activation. , 2008, The Journal of clinical investigation.

[53]  K. Nair,et al.  Age, Obesity, and Sex Effects on Insulin Sensitivity and Skeletal Muscle Mitochondrial Function , 2009, Diabetes.

[54]  W. Saris,et al.  Metabolic flexibility in the development of insulin resistance and type 2 diabetes: effects of lifestyle , 2009, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[55]  M. Davison,et al.  Moderate daily exercise activates metabolic flexibility to prevent prenatally induced obesity. , 2009, Endocrinology.

[56]  L. Koch,et al.  Skeletal muscle mitochondrial and metabolic responses to a high-fat diet in female rats bred for high and low aerobic capacity. , 2010, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[57]  T. Ketola,et al.  Gene expression centroids that link with low intrinsic aerobic exercise capacity and complex disease risk , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.